Skip to main content
NCBI home page
Gut logoLink to Gut
. 1993 Jul;34(7):944–947. doi: 10.1136/gut.34.7.944

Insulin like growth factor-I, insulin like growth factor binding protein-1, and insulin in childhood Crohn's disease.

A G Thomas 1, J M Holly 1, F Taylor 1, V Miller 1
PMCID: PMC1374231  PMID: 7688335

Abstract

Twenty nine children with Crohn's disease were studied before and after treatment with steroids or an elemental diet to assess the effect of disease activity and treatment on serum insulin like growth factor I (IGF-I), insulin like growth factor binding protein (IGFBP-1), and insulin concentrations. The median serum IGF-I concentration was lower in patients with active disease than in matched controls, and lower in stunted than well grown patients, but insulin and IGFBP-1 concentrations were not significantly different between any group. After four weeks of either treatment there was an increase in the median serum IGF-I concentration; this was greater in the steroid group than the elemental diet group. The median serum insulin concentration increased and median serum IGFBP-1 concentration decreased in the steroid treated group but not in the elemental diet group. These changes were accompanied by a greater and more sustained increase in energy intake in the steroid group. Despite this the median height velocity SD score was greater in the elemental diet group than in the steroid group.

Full text

PDF
944

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cianfarani S., Holly J. M. Somatomedin-binding proteins: what role do they play in the growth process? Eur J Pediatr. 1989 Nov;149(2):76–79. doi: 10.1007/BF01995850. [DOI] [PubMed] [Google Scholar]
  2. Farthing M. J., Campbell C. A., Walker-Smith J., Edwards C. R., Rees L. H., Dawson A. M. Nocturnal growth hormone and gonadotrophin secretion in growth retarded children with Crohn's disease. Gut. 1981 Nov;22(11):933–938. doi: 10.1136/gut.22.11.933. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Gotlin R. W., Dubois R. S. Nyctohemeral growth hormone levels in children with growth retardation and inflammatory bowel disease. Gut. 1973 Mar;14(3):191–195. doi: 10.1136/gut.14.3.191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Hintz R. L. The somatomedins. Adv Pediatr. 1981;28:293–317. [PubMed] [Google Scholar]
  5. Holly J. M., Dunger D. B., Edge J. A., Smith C. P., Chard T., Wass J. A. Insulin-like growth factor binding protein-1 levels in diabetic adolescents and their relationship to metabolic control. Diabet Med. 1990 Aug;7(7):618–623. doi: 10.1111/j.1464-5491.1990.tb01460.x. [DOI] [PubMed] [Google Scholar]
  6. Holly J. M. The physiological role of IGFBP-1. Acta Endocrinol (Copenh) 1991;124 (Suppl 2):55–62. [PubMed] [Google Scholar]
  7. Kelts D. G., Grand R. J., Shen G., Watkins J. B., Werlin S. L., Boehme C. Nutritional basis of growth failure in children and adolescents with Crohn's disease. Gastroenterology. 1979 Apr;76(4):720–727. [PubMed] [Google Scholar]
  8. Kirschner B. S., Sutton M. M. Somatomedin-C levels in growth-impaired children and adolescents with chronic inflammatory bowel disease. Gastroenterology. 1986 Oct;91(4):830–836. doi: 10.1016/0016-5085(86)90683-9. [DOI] [PubMed] [Google Scholar]
  9. Lloyd-Still J. D., Green O. C. A clinical scoring system for chronic inflammatory bowel disease in children. Dig Dis Sci. 1979 Aug;24(8):620–624. doi: 10.1007/BF01333706. [DOI] [PubMed] [Google Scholar]
  10. McCaffery T. D., Jr, Nasr K., Lawrence A. M., Kirsner J. B. Effect of administered human growth hormone on growth retardation in inflammatory bowel disease. Am J Dig Dis. 1974 May;19(5):411–416. doi: 10.1007/BF01255604. [DOI] [PubMed] [Google Scholar]
  11. McCaffery T. D., Nasr K., Lawrence A. M., Kirsner J. B. Severe growth retardation in children with inflammatory bowel disease. Pediatrics. 1970 Mar;45(3):386–393. [PubMed] [Google Scholar]
  12. Mohan P. S., Jaya Rao K. S. Plasma somatomedin activity in protein calorie malnutrition. Arch Dis Child. 1979 Jan;54(1):62–64. doi: 10.1136/adc.54.1.62. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Phillips L. S., Vassilopoulou-Sellin R. Somatomedins (first of two parts). N Engl J Med. 1980 Feb 14;302(7):371–380. doi: 10.1056/NEJM198002143020704. [DOI] [PubMed] [Google Scholar]
  14. Phillips L. S., Vassilopoulou-Sellin R. Somatomedins (second of two parts). N Engl J Med. 1980 Feb 21;302(8):438–446. doi: 10.1056/NEJM198002213020805. [DOI] [PubMed] [Google Scholar]
  15. Rappaport R., Prevot C., Czernichow P. Somatomedin activity and growth hormone secretion. I. Changes related to body weight in anorexia nervosa. Acta Paediatr Scand. 1980 Jan;69(1):37–41. doi: 10.1111/j.1651-2227.1980.tb07026.x. [DOI] [PubMed] [Google Scholar]
  16. Sanderson I. R., Udeen S., Davies P. S., Savage M. O., Walker-Smith J. A. Remission induced by an elemental diet in small bowel Crohn's disease. Arch Dis Child. 1987 Feb;62(2):123–127. doi: 10.1136/adc.62.2.123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Smith C. P., Dunger D. B., Williams A. J., Taylor A. M., Perry L. A., Gale E. A., Preece M. A., Savage M. O. Relationship between insulin, insulin-like growth factor I, and dehydroepiandrosterone sulfate concentrations during childhood, puberty, and adult life. J Clin Endocrinol Metab. 1989 May;68(5):932–937. doi: 10.1210/jcem-68-5-932. [DOI] [PubMed] [Google Scholar]
  18. Tanner J. M., Whitehouse R. H. Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child. 1976 Mar;51(3):170–179. doi: 10.1136/adc.51.3.170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Tanner J. M., Whitehouse R. H., Takaishi M. Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. II. Arch Dis Child. 1966 Dec;41(220):613–635. doi: 10.1136/adc.41.220.613. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Tenore A., Berman W. F., Parks J. S., Bongiovanni A. M. Basal and stimulated serum growth hormone concentrations in inflammatory bowel disease. J Clin Endocrinol Metab. 1977 Apr;44(4):622–628. doi: 10.1210/jcem-44-4-622. [DOI] [PubMed] [Google Scholar]
  21. Waterlow J. C. Note on the assessment and classification of protein-energy malnutrition in children. Lancet. 1973 Jul 14;2(7820):87–89. doi: 10.1016/s0140-6736(73)93276-5. [DOI] [PubMed] [Google Scholar]
  22. Winter R. J., Phillips L. S., Green O. C., Traisman H. S. Somatomedin activity in the Mauriac syndrome. J Pediatr. 1980 Oct;97(4):598–600. doi: 10.1016/s0022-3476(80)80017-5. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES